Microarrays as cancer keys: an array of possibilities.

Malignant transformation results from accumulation of genetic and epigenetic events. Functional studies of cancer will be crucial to our understanding of its complexity and polymorphism. There is no doubt that emerging genomic and proteomic technologies will facilitate such investigations. Microarray technology is a new and efficient approach to extract data of biomedical relevance for a wide range of applications. In cancer research, it will provide high-throughput and valuable insights into differences in an individual's tumor as compared with constitutional DNA, mRNA expression, and protein expression and activity. Across individuals, comparisons could provide tissue-specific disease signatures that provide diagnosis based on hundreds of informative genes. The resulting product should be a wealth of tumor-associated and tumor-specific biomarkers, which may help in cancer etiology, diagnosis, and therapy and ultimately lead to "molecular nosology" of cancers. This review highlights the recent developments in microarray technologies in cancer research, focuses on the results obtained so far, and describes the eventual use of microarray technology for clinical applications.

[1]  P. Goodfellow,et al.  DNA microarrays in drug discovery and development , 1999, Nature Genetics.

[2]  T. Kodadek.  Protein microarrays: prospects and problems. , 2001, Chemistry & biology.

[3]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[4]  J. Isola,et al.  High topoisomerase IIα expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas , 2000, Neuropathology and applied neurobiology.

[5]  C. Wood,et al.  Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway. , 2001, Cancer research.

[6]  R. Dunn,et al.  Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  J. Harney,et al.  The Human Type 2 Iodothyronine Deiodinase Is a Selenoprotein Highly Expressed in a Mesothelioma Cell Line* , 2001, The Journal of Biological Chemistry.

[8]  Emanuel Petricoin,et al.  Molecular profiling of human cancer , 2000, Nature Reviews Genetics.

[9]  Joel H. Saltz,et al.  Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. , 1999, Cancer research.

[10]  K. Senior.  Fingerprinting disease with protein chip arrays. , 1999, Molecular medicine today.

[11]  Kylie L. Gorringe,et al.  Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers : a new approach for the molecular analysis of paraffin-embedded cancer tissue. , 2001, The American journal of pathology.

[12]  H. Davies,et al.  Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research. , 2000, BioTechniques.

[13]  A. Mirzabekov,et al.  Sequencing by Hybridization with the Generic 6-mer Oligonucleotide Microarray: An Advanced Scheme for Data Processing , 2000, Journal of biomolecular structure & dynamics.

[14]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Christopherson,et al.  Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. , 2001, Cancer research.

[16]  D Haussler,et al.  Knowledge-based analysis of microarray gene expression data by using support vector machines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[18]  A. Holmgren,et al.  Up‐regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma , 2001, International journal of cancer.

[19]  U. Alon,et al.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Petricoin,et al.  Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front , 2001, Oncogene.

[21]  M. Waalkes,et al.  Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  Holger Moch,et al.  Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade , 2001, The Journal of pathology.

[23]  J. Hacia,et al.  Oligonucleotide microarray based detection of repetitive sequence changes , 2000, Human mutation.

[24]  L. Aaltonen,et al.  Comparison of Serous and Mucinous Ovarian Carcinomas: Distinct Pattern of Allelic Loss at Distal 8p and Expression of Transcription Factor GATA-4 , 2001, Laboratory Investigation.

[25]  H. Sonobe,et al.  Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2α , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Croce,et al.  Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality , 2001, Oncogene.

[27]  U. Şahin,et al.  Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices , 1999, Nature Biotechnology.

[28]  J. Trent,et al.  Microarrays and toxicology: The advent of toxicogenomics , 1999, Molecular carcinogenesis.

[29]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[30]  L. Horvath,et al.  THE APPLICATION OF TISSUE MICROARRAYS TO CANCER RESEARCH , 2001, Pathology.

[31]  D Pinkel,et al.  High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. , 2001, Human molecular genetics.

[32]  K. Kinzler,et al.  Serial Analysis of Gene Expression , 1995, Science.

[33]  D J Lockhart,et al.  Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. , 2000, Genome research.

[34]  Y. Chen,et al.  Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. , 2000, Cancer research.

[35]  M. Bittner,et al.  Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. , 2000, Cancer research.

[36]  M. Snyder,et al.  Protein arrays and microarrays. , 2001, Current opinion in chemical biology.

[37]  S. P. Fodor,et al.  Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two–colour fluorescence analysis , 1996, Nature Genetics.

[38]  Francis Barany,et al.  Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2 , 2000, Nature Biotechnology.

[39]  J. J. Chen,et al.  Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray. , 2000, American journal of respiratory cell and molecular biology.

[40]  R. Altman,et al.  Whole-genome expression analysis: challenges beyond clustering. , 2001, Current opinion in structural biology.

[41]  B. Vikram,et al.  Cell lines from the same cervical carcinomabut with different radiosensitivities exhibit different cDNA microarray patterns of gene expression , 2001, Cytogenetic and Genome Research.

[42]  J. Mesirov,et al.  Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Brazma,et al.  Gene expression data analysis , 2000, FEBS letters.

[44]  H. Moch,et al.  Tissue microarrays for gene amplification surveys in many different tumor types. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  Søren Buus,et al.  Tumor‐associated antigens identified by mRNA expression profiling induce protective anti‐tumor immunity , 2001, European journal of immunology.

[46]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[47]  K. Jain.  Applications of proteomics in oncology. , 2000, Pharmacogenomics.

[48]  J M Trent,et al.  MYB oncogene amplification in hereditary BRCA1 breast cancer. , 2000, Cancer research.

[49]  T Tanaka,et al.  Identification by cDNA microarray of genes involved in ovarian carcinogenesis. , 2000, Cancer research.

[50]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[51]  B. Rihn,et al.  [Gene expression profiling in human mesothelioma cells using DNA microarray and high-density filter array technologies]. , 2001, Bulletin du cancer.

[52]  Ash A. Alizadeh,et al.  Genome-wide analysis of DNA copy-number changes using cDNA microarrays , 1999, Nature Genetics.

[53]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[54]  A. Berno,et al.  High-throughput polymorphism screening and genotyping with high-density oligonucleotide arrays. , 1999, Genetic analysis : biomolecular engineering.

[55]  M. Mann,et al.  Proteomics to study genes and genomes , 2000, Nature.

[56]  O. Kallioniemi,et al.  Genome screening by comparative genomic hybridization. , 1997, Trends in genetics : TIG.

[57]  Jie Liu,et al.  Genetic events associated with arsenic‐induced malignant transformation: applications of cDNA microarray technology † , 2001, Molecular carcinogenesis.

[58]  D. Rimm,et al.  Validation of Tissue Microarray Technology in Breast Carcinoma , 2000, Laboratory Investigation.

[59]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[60]  G. Leikauf,et al.  Differential gene expression in mesothelioma , 2000, FEBS letters.

[61]  C Stratowa,et al.  CDNA microarray gene expression analysis of B‐cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking , 2001, International journal of cancer.

[62]  E. Dougherty,et al.  Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.

[63]  K. Becker,et al.  Antisense DNAs as multisite genomic modulators identified by DNA microarray , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[64]  William D. Hinsberg,et al.  DNA sequencing on a chip , 1997 .

[65]  Peng Huang,et al.  Superoxide dismutase as a target for the selective killing of cancer cells , 2000, Nature.

[66]  A. Butte,et al.  Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. , 2000, The New England journal of medicine.

[67]  T C Gasser,et al.  Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. , 1999, Cancer research.

[68]  G. Sherlock.  Analysis of large-scale gene expression data. , 2000, Current opinion in immunology.

[69]  M. Rubin,et al.  Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors. , 2001, Cancer research.

[70]  Eric S. Lander,et al.  Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays , 2000, Nature Biotechnology.

[71]  A. Roses.  Pharmacogenetics and the practice of medicine , 2000, Nature.

[72]  M. White,et al.  Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis. , 2000, Cancer research.

[73]  J. Barrett,et al.  Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. , 1999, Cancer research.